This website uses cookies to enhance the user experience.
21st logo
||
A

AHLQVIST INVEST AS988 888 370

Limited company
Vinterveien 5 4041 HAFRSFJORD, Norge

AHLQVIST INVEST AS

Operating
Kjøp og salg av verdipapirer, investering i andre selskaper med lignende virksomhet og hva hermed står i forbindelse.
Kjøp og salg av aksjer og verdipapirer samt delta i selskaper med lignende virksomhet og hva hermed står i forbindelse.

Organization

Chairman of the board
Years since formation
21 years
since Nov 12, 2005
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
1
person

Financials

Annual total result 2025
2,291,540
NOK
Total equity 2025
20,692,428
NOK
Last update: Jun 25, 2026

Management

Board

NameRoleShares
Chairman
100 %
directly
Board Member-
Alternate Member-

Others

NameRoleShares
S
SANNA REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Chairman
100 %
directly
Last update: Sep 24, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
100
100 %

Shares owned by the AHLQVIST INVEST AS

NameShare classTotal number of sharesShare
N
NORKYST AS
Ordinary shares
57,814
4.93 %
P
PALEBLUE AS
Ordinary shares
84,516
3.22 %
O
OPTIMARIN AS
Class B shares
138,031
1.85 %
I
INTOTO AS
Ordinary shares
60,000
1 %
Ordinary shares
39,525
0.09 %
A
ANZYZ TECHNOLOGIES AS
Ordinary shares
30,845
0.09 %
A
ASCENIUM HOLDING AS
Ordinary shares
338,000
0.07 %
D
DELLIA GROUP ASA
Ordinary shares
3,010
0.06 %
N
NORSK RENEWABLES AS
Ordinary shares
20,930
< 0.01 %
P
PEXIP HOLDING ASA
Ordinary shares
8,626
< 0.01 %
N
NORDIC TECHNOLOGY GROUP AS
Ordinary shares
15,130
< 0.01 %
S
SPAREBANK 1 SØR-NORGE ASA
Ordinary shares
10
< 0.01 %
S
SALMAR ASA
Ordinary shares
100
< 0.01 %
N
NORDIC SEMICONDUCTOR ASA
Ordinary shares
1,829
< 0.01 %
I
IDEX BIOMETRICS ASA
Ordinary shares
540
< 0.01 %
D
DNB BANK ASA
Ordinary shares
1,307
< 0.01 %
A
AKER BP ASA
Ordinary shares
1,742
< 0.01 %
L
LIFECARE ASA
Ordinary shares
1,385
< 0.01 %
N
NYKODE THERAPEUTICS ASA
Ordinary shares
20,000
< 0.01 %
W
WALLENIUS WILHELMSEN ASA
Ordinary shares
4,000
< 0.01 %
E
EUROPRIS ASA
Ordinary shares
2,306
< 0.01 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
31,500
Annual Total Result
2,291,540
1,377,903
1,302,985
-3,423,250
-1,128,727
Total assets
20,719,448
18,528,014
17,840,923
16,541,608
20,976,262
Total liabilities
27,020
127,127
117,939
121,608
1,133,012
Total equity
20,692,428
18,400,887
17,722,984
16,420,000
19,843,250

P&L

Year20252024202320222021
Total operating income
0
0
0
0
31,500
Total operating costs
-76,328
57,726
80,890
17,576
41,306
Operating result
76,328
-57,726
-80,890
-17,576
-9,806
Financial income/costs
2,242,232
1,446,443
1,385,501
-3,400,379
-1,102,223
Profit before tax
2,318,560
1,388,717
1,304,611
-3,417,955
-1,112,028
Total tax & extraordinary income/cost
27,020
10,814
1,626
5,295
16,699
Annual Total Result
2,291,540
1,377,903
1,302,985
-3,423,250
-1,128,727

Balance overview

Year20252024202320222021
Total fixed assets
6,845,330
6,471,667
6,539,216
7,437,967
6,603,474
Total current assets
13,874,118
12,056,347
11,301,707
9,103,640
14,372,787
Total assets
20,719,448
18,528,014
17,840,923
16,541,608
20,976,262
Short term debt
27,020
127,127
117,939
121,608
1,133,012
Long term debt
0
0
0
0
0
Total liabilities
27,020
127,127
117,939
121,608
1,133,012
Contributed capital
100,000
100,000
100,000
100,000
100,000
Retained earnings
20,592,428
18,300,887
17,622,984
16,320,000
19,743,250
Total equity
20,692,428
18,400,887
17,722,984
16,420,000
19,843,250
Total equity and liabilities
20,719,448
18,528,014
17,840,923
16,541,608
20,976,262

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Standard industrial classification